Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.88 |
| ▸ | LPL | P06858 | 12/20 | 0.88 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14506127 | 1.00 | LIPG (0.88) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL431713 | 1.00 | LIPG (0.88) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL19428979 | 0.98 | LIPG (0.85) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL15678312 | 0.98 | LIPG (0.85) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL27254683 | 0.95 | LIPG (0.80) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL27254410 | 0.95 | LIPG (0.80) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL29892456 | 0.93 | LIPG (1.00) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL440456 | 0.93 | LIPG (1.00) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL15197479 | 0.93 | LIPG (1.00) | LIPGLPLESR1ESR2SNCA | |
| SCHEMBL15600537 | 0.93 | LIPG (1.00) | LIPGLPLESR1ESR2SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122162-A1 | ORGANIC COMPOUND, ORGANIC SEMICONDUCTOR DEVICE, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-04-17 | — | — | US | disclosed |
| US-20250084302-A1 | ORGANIC COMPOUND AND LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-03-13 | — | — | US | disclosed |
| US-20240336585-A1 | Organic Compound, Organic Semiconductor Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336585-A1 | Organic Compound, Organic Semiconductor Device, and Electronic Appliance | ACVRL1, ASH2L, ARL1 | LIPG 4737/4885LPL 3579/4885ESR1 324/4885 |
| US-20250122162-A1 | ORGANIC COMPOUND, ORGANIC SEMICONDUCTOR DEVICE, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE | CCNT1, CNOT1, SULT1A1 | LIPG 4243/4885LPL 4006/4885ESR1 207/4885 |
| US-20250084302-A1 | ORGANIC COMPOUND AND LIGHT-EMITTING DEVICE | CRY1, C1S, DRD1 | LIPG 3088/4885LPL 2641/4885ESR1 116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.